119 related articles for article (PubMed ID: 11296032)
1. Latanoprost and periocular skin color changes.
Wand M; Ritch R; Isbey EK; Zimmerman TJ
Arch Ophthalmol; 2001 Apr; 119(4):614-5. PubMed ID: 11296032
[No Abstract] [Full Text] [Related]
2. The clinical impact and incidence of periocular pigmentation associated with either latanoprost or bimatoprost therapy.
Sharpe ED; Reynolds AC; Skuta GL; Jenkins JN; Stewart WC
Curr Eye Res; 2007 Dec; 32(12):1037-43. PubMed ID: 18085467
[TBL] [Abstract][Full Text] [Related]
3. Severe darkening of a facial skin graft from latanoprost.
Calladine D; Harrison RJ
Arch Ophthalmol; 2007 Oct; 125(10):1427-8. PubMed ID: 17923558
[No Abstract] [Full Text] [Related]
4. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.
Herndon LW; Robert D Williams ; Wand M; Asrani S
Am J Ophthalmol; 2003 May; 135(5):713-5. PubMed ID: 12719085
[TBL] [Abstract][Full Text] [Related]
5. Incidence and severity of iris pigmentation on latanoprost-treated glaucoma eyes.
Chou SY; Chou CK; Kuang TM; Hsu WM
Eye (Lond); 2005 Jul; 19(7):784-7. PubMed ID: 15359238
[TBL] [Abstract][Full Text] [Related]
6. Response to case study on darkening of a facial skin graft after latanoprost.
Digger RC
Arch Ophthalmol; 2011 Jul; 129(7):964-5. PubMed ID: 21746996
[No Abstract] [Full Text] [Related]
7. Latanoprost and hyperpigmentation of eyelashes.
Wand M
Arch Ophthalmol; 1997 Sep; 115(9):1206-8. PubMed ID: 9298071
[No Abstract] [Full Text] [Related]
8. Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma.
Nakamura Y; Nakamura Y; Morine-Shinjo S; Sakai H; Sawaguchi S
Acta Ophthalmol Scand; 2004 Apr; 82(2):158-60. PubMed ID: 15043533
[TBL] [Abstract][Full Text] [Related]
9. Five-year, multicenter safety study of fixed-combination latanoprost/timolol (Xalacom) for open-angle glaucoma and ocular hypertension.
Alm A; Grunden JW; Kwok KK
J Glaucoma; 2011; 20(4):215-22. PubMed ID: 20520568
[TBL] [Abstract][Full Text] [Related]
10. Systemic side effects of topical latanoprost.
Rajan MS; Syam P; Liu C
Eye (Lond); 2003 Apr; 17(3):442-4. PubMed ID: 12724721
[No Abstract] [Full Text] [Related]
11. Latanoprost-induced Skin Depigmentation.
Lin M; Schmutz M; Mosaed S
J Glaucoma; 2017 Nov; 26(11):e246-e248. PubMed ID: 29099736
[TBL] [Abstract][Full Text] [Related]
12. Latisse-induced periocular skin hyperpigmentation.
Priluck JC; Fu S
Arch Ophthalmol; 2010 Jun; 128(6):792-3. PubMed ID: 20547960
[No Abstract] [Full Text] [Related]
13. A case of latanoprost-induced diffuse facial skin hyperpigmentation.
Kim HY; Lee SK; Lee JH; Suh JH; Kim MS; Lee UH
J Cosmet Dermatol; 2019 Dec; 18(6):1717-1720. PubMed ID: 30924263
[TBL] [Abstract][Full Text] [Related]
14. [Latanoprost (Xalatan) and a systemic respiratory effect? Apropos of a case].
Veyrac G; Chiffoleau A; Cellerin L; Larousse C; Bourin M
Therapie; 1999; 54(4):494-6. PubMed ID: 10667120
[No Abstract] [Full Text] [Related]
15. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans.
Sodhi PK; Verma L; Ratan SK
Am J Ophthalmol; 2004 Apr; 137(4):783. PubMed ID: 15059736
[No Abstract] [Full Text] [Related]
16. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma.
Alm A; Schoenfelder J; McDermott J
Arch Ophthalmol; 2004 Jul; 122(7):957-65. PubMed ID: 15249358
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma.
Ekatomatis P
Br J Ophthalmol; 2001 Aug; 85(8):1008-9. PubMed ID: 11501520
[No Abstract] [Full Text] [Related]
18. Allergic contact dermatitis caused by topical eye drops.
Spaeth GL
Am J Ophthalmol; 2006 Oct; 142(4):706. PubMed ID: 17011880
[No Abstract] [Full Text] [Related]
19. Migraine headache associated with latanoprost.
Weston BC
Arch Ophthalmol; 2001 Feb; 119(2):300-1. PubMed ID: 11176999
[No Abstract] [Full Text] [Related]
20. Latanoprost-related transient incontinence.
Raja V; Sandanshiv P; Asghar M; Moriarty B
Clin Exp Ophthalmol; 2007; 35(4):389-90. PubMed ID: 17539800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
